• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » COVID-19

COVID-19
COVID-19 RSS Feed RSS

FDA Not Ready for Innovation Guidance Yet, Acting Commissioner Says

April 19, 2021
Decentralized clinical trials are here to stay, but the FDA won’t be ready to move forward with more formal recommendations until the pandemic is over, according to Acting Commissioner Janet Woodcock. Read More

Analysis Shows Only 14 Percent of U.S. COVID-19 Trials Completed

April 19, 2021
A new analysis by the Clinical Trials Transformation Initiative (CTTI) shows just 14 percent of U.S. COVID-19 studies launched during the pandemic were completed. While the remaining 86 percent of trials remain active, many have either not reported results or will never be completed. Read More

COVID-19 Update

April 19, 2021
COVID-19 Drug Research Roundup Read More

Study Finds Pandemic Mitigation Efforts Impacted Trial Completion Rates

April 12, 2021
A new study finds that trials sponsored by the pharma industry fared better during the pandemic and were more likely to complete enrollment compared to trials sponsored by academia, hospitals and medical centers. Read More

COVID-19 Update

April 12, 2021
COVID-19 Drug Research Roundup Read More

COVID-19 Update

April 5, 2021
COVID-19 Drug Research Roundup Read More

COVID-19 Update

March 29, 2021
COVID-19 Drug Research Roundup Read More

WHO Considers Launching Global COVID-19 Vaccine Trial

March 22, 2021
The World Health Organization (WHO) is considering launching a global platform trial by July to test three to four COVID-19 vaccines against placebo in partnership with several unnamed vaccine developers. Read More

More than 300 COVID-19 Trials Reviewed by FDA’s New Drugs Office in 2020

March 22, 2021
Despite the unprecedented disruption and shift in priorities that COVID-19 brought to FDA’s Office of New Drugs (OND) in 2020, the office’s annual report shows it reviewed more than 320 trials for potential COVID-19 therapeutics and more than 570 drug development programs in the planning stages. Read More

COVID-19 Update

March 22, 2021
COVID-19 Drug Research Roundup Read More
Previous 1 2 3 4 5 6 7 8 9 … 21 22 Next

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing